JP2012017316A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012017316A5 JP2012017316A5 JP2011033976A JP2011033976A JP2012017316A5 JP 2012017316 A5 JP2012017316 A5 JP 2012017316A5 JP 2011033976 A JP2011033976 A JP 2011033976A JP 2011033976 A JP2011033976 A JP 2011033976A JP 2012017316 A5 JP2012017316 A5 JP 2012017316A5
- Authority
- JP
- Japan
- Prior art keywords
- bnp
- cnp
- external preparation
- skin
- preparation composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000012421 C-Type Natriuretic Peptide Human genes 0.000 claims 28
- 101800000060 C-type natriuretic peptide Proteins 0.000 claims 28
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 claims 24
- 239000000203 mixture Substances 0.000 claims 18
- 150000001413 amino acids Chemical class 0.000 claims 14
- 102400000667 Brain natriuretic peptide 32 Human genes 0.000 claims 5
- 101800000457 CNP-22 Proteins 0.000 claims 5
- 101800002247 Brain natriuretic peptide 45 Proteins 0.000 claims 4
- 101800000433 CNP-53 Proteins 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 239000007788 liquid Substances 0.000 claims 4
- UHSBKBYWHCBDCJ-DYGWFTAGSA-N natriuretic peptide, c-type Chemical compound N1C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CN)CSSC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CC1=CC=CC=C1 UHSBKBYWHCBDCJ-DYGWFTAGSA-N 0.000 claims 4
- 108010028149 porcine brain natriuretic peptide Proteins 0.000 claims 4
- FDDRPVDFHFQYQZ-OAQDCNSJSA-N brain natriuretic peptide-32 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CO)C(C)C)C1=CC=CC=C1 FDDRPVDFHFQYQZ-OAQDCNSJSA-N 0.000 claims 3
- 108091006116 chimeric peptides Proteins 0.000 claims 3
- 239000006071 cream Substances 0.000 claims 3
- 239000002552 dosage form Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- 239000006210 lotion Substances 0.000 claims 2
- 239000002674 ointment Substances 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 206010013786 Dry skin Diseases 0.000 claims 1
- 239000002585 base Substances 0.000 claims 1
- 239000003788 bath preparation Substances 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 239000003599 detergent Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000037336 dry skin Effects 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 239000000686 essence Substances 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 230000037307 sensitive skin Effects 0.000 claims 1
- 239000000344 soap Substances 0.000 claims 1
- 230000000475 sunscreen effect Effects 0.000 claims 1
- 239000000516 sunscreening agent Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011033976A JP5778440B2 (ja) | 2009-07-23 | 2011-02-18 | 皮膚外用剤組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009172589 | 2009-07-23 | ||
| JP2009172589 | 2009-07-23 | ||
| JP2010134600 | 2010-06-11 | ||
| JP2010134600 | 2010-06-11 | ||
| JP2011033976A JP5778440B2 (ja) | 2009-07-23 | 2011-02-18 | 皮膚外用剤組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011507738A Division JP4834190B2 (ja) | 2009-07-23 | 2010-07-23 | 皮膚外用剤組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015137445A Division JP6055518B2 (ja) | 2009-07-23 | 2015-07-09 | 皮膚外用剤組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012017316A JP2012017316A (ja) | 2012-01-26 |
| JP2012017316A5 true JP2012017316A5 (enExample) | 2014-08-28 |
| JP5778440B2 JP5778440B2 (ja) | 2015-09-16 |
Family
ID=43499204
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011507738A Active JP4834190B2 (ja) | 2009-07-23 | 2010-07-23 | 皮膚外用剤組成物 |
| JP2011033976A Active JP5778440B2 (ja) | 2009-07-23 | 2011-02-18 | 皮膚外用剤組成物 |
| JP2015137445A Active JP6055518B2 (ja) | 2009-07-23 | 2015-07-09 | 皮膚外用剤組成物 |
| JP2016234905A Active JP6337071B2 (ja) | 2009-07-23 | 2016-12-02 | 皮膚外用剤組成物 |
| JP2018089006A Withdrawn JP2018135381A (ja) | 2009-07-23 | 2018-05-07 | 皮膚外用剤組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011507738A Active JP4834190B2 (ja) | 2009-07-23 | 2010-07-23 | 皮膚外用剤組成物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015137445A Active JP6055518B2 (ja) | 2009-07-23 | 2015-07-09 | 皮膚外用剤組成物 |
| JP2016234905A Active JP6337071B2 (ja) | 2009-07-23 | 2016-12-02 | 皮膚外用剤組成物 |
| JP2018089006A Withdrawn JP2018135381A (ja) | 2009-07-23 | 2018-05-07 | 皮膚外用剤組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20120208756A1 (enExample) |
| EP (1) | EP2457581B1 (enExample) |
| JP (5) | JP4834190B2 (enExample) |
| KR (2) | KR101533695B1 (enExample) |
| CN (4) | CN105999230B (enExample) |
| AU (1) | AU2010274293B9 (enExample) |
| BR (1) | BR112012001491B1 (enExample) |
| CA (1) | CA2768810C (enExample) |
| DK (1) | DK2457581T3 (enExample) |
| ES (1) | ES2456502T3 (enExample) |
| MX (1) | MX2012001024A (enExample) |
| NZ (1) | NZ597797A (enExample) |
| RU (2) | RU2572694C2 (enExample) |
| WO (1) | WO2011010732A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120208756A1 (en) | 2009-07-23 | 2012-08-16 | Igisu Co., Ltd | Composition for external preparation for skin |
| HUE035584T2 (en) | 2011-01-21 | 2018-05-28 | Igisu Co Ltd | A therapeutic agent for the treatment of allopathy |
| ES2488740B1 (es) * | 2012-10-10 | 2015-06-11 | J. Álvaro GALIANO RAMOS | Formulación cosmética y dermatologica para el alivio del prurito |
| CN104367925A (zh) * | 2014-11-07 | 2015-02-25 | 济南高达信息技术有限公司 | 一种治疗红皮病的中药洗剂及其制备方法 |
| CN107709352A (zh) | 2015-05-29 | 2018-02-16 | Igisu株式会社 | 环肽以及含有该环肽的药物、外用剂和化妆品 |
| WO2016204959A1 (en) | 2015-06-19 | 2016-12-22 | Global Health Solutions, Inc. | Petrolatum-based delivery systems and for active ingredients |
| JP7253220B2 (ja) * | 2015-07-31 | 2023-04-06 | 株式会社 イギス | Ｃｎｐ環状ペプチド並びに該環状ペプチドを含む医薬品、外用剤および化粧料 |
| CN105617360B (zh) * | 2015-12-04 | 2018-12-21 | 中国农业大学 | C-型钠肽在制备外用避孕药和精子功能检测试剂中的应用 |
| JP7653218B2 (ja) | 2016-05-05 | 2025-03-28 | アクエスティブ セラピューティクス インコーポレイテッド | 送達増強エピネフリン組成物 |
| US20170290776A1 (en) * | 2016-05-05 | 2017-10-12 | Monosol Rx, Llc | Pharmaceutical compositions with enhanced permeation |
| US20200030411A1 (en) * | 2016-09-21 | 2020-01-30 | Agency For Science, Technology And Research | Methods and Compositions for Inhibiting Skin Inflammation and Determining Cancer Susceptibility |
| JP7125862B2 (ja) * | 2018-05-29 | 2022-08-25 | 小林製薬株式会社 | 外用組成物 |
| JP2019214520A (ja) * | 2018-06-12 | 2019-12-19 | 花王株式会社 | 角層剥離改善剤 |
| CN110302194B (zh) * | 2019-07-23 | 2023-01-31 | 广州市皮肤病防治所(广州市性病防治监测中心) | 一种具有抗炎和皮肤屏障保护作用的桉叶素联合糖皮质激素的复方制剂 |
| US11419917B2 (en) | 2020-04-07 | 2022-08-23 | Drora Shevy | Treatment for SARS-CoV-2 and other coronaviruses |
| US12465564B2 (en) | 2021-10-25 | 2025-11-11 | Aquestive Therapeutics, Inc. | Oral and nasal compositions and methods of treatment |
| JP7466939B2 (ja) * | 2022-08-31 | 2024-04-15 | 東洋ビューティ株式会社 | Ｏ／ｄ相組成物及び水中油型乳化組成物 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5114923A (en) | 1988-05-31 | 1992-05-19 | California Biotechnology Inc. | Recombinant techniques for production of novel natriuretic and vasodilator peptides |
| JP2809533B2 (ja) * | 1991-01-31 | 1998-10-08 | 壽之 松尾 | Ｃｎｐ類似体ペプチド |
| JPH05207891A (ja) | 1991-03-08 | 1993-08-20 | Shionogi & Co Ltd | 脳性ナトリウム利尿ペプチドの製造方法 |
| AU6360394A (en) | 1993-03-03 | 1994-09-26 | Mayo Foundation For Medical Education And Research | Vasonatrin peptide and analogs thereof |
| US6028055A (en) | 1996-10-22 | 2000-02-22 | Genetech, Inc. | Receptor selective BNP |
| US5965533A (en) | 1997-05-23 | 1999-10-12 | Baxter International Inc. | Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions |
| JP3799465B2 (ja) | 1998-09-28 | 2006-07-19 | 参天製薬株式会社 | ナトリウム利尿ペプチドを有効成分とする涙液分泌促進または角結膜障害治療用点眼剤 |
| CA2345414A1 (en) | 1998-09-28 | 2000-04-06 | Santen Pharmaceutical Co., Ltd. | Eyedrops for promoting lacrimal secretion or treating keratoconjunctival disorders containing natriuretic peptide as active ingredient |
| US6407211B1 (en) * | 1999-12-17 | 2002-06-18 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic peptides |
| IL142118A0 (en) | 2001-03-20 | 2002-03-10 | Prochon Biotech Ltd | Method and composition for treatment of skeletal dysplasias |
| JP3676707B2 (ja) * | 2001-07-18 | 2005-07-27 | 三菱電機株式会社 | 車両用交流発電機の固定子およびその製造方法 |
| US7655772B2 (en) | 2002-09-06 | 2010-02-02 | University Of South Florida | Materials and methods for treatment of allergic diseases |
| US20050271596A1 (en) | 2002-10-25 | 2005-12-08 | Foamix Ltd. | Vasoactive kit and composition and uses thereof |
| US7648962B2 (en) * | 2002-11-26 | 2010-01-19 | Biocon Limited | Natriuretic compounds, conjugates, and uses thereof |
| EP1569683B1 (en) | 2002-11-26 | 2010-03-03 | Biocon Limited | Modified natriuretic compounds, conjugates, and uses thereof |
| US20040161435A1 (en) * | 2003-02-14 | 2004-08-19 | Gupta Shyam K. | Skin Firming Anti-Aging Cosmetic Mask Compositions |
| BRPI0411410A (pt) * | 2003-06-13 | 2006-07-25 | Daiichi Asubio Pharma Co Ltd | composições farmacêuticas para a prevenção ou tratamento de doenças imunes mediadas por th1 |
| DE602004029680D1 (de) * | 2003-06-20 | 2010-12-02 | Mayo Foundation | Isoformen von gehirn-natriuretischem peptid |
| EP1730181A2 (en) | 2004-01-27 | 2006-12-13 | Compugen USA, Inc. | Novel brain natriuretic peptide variants and methods of use thereof |
| JP2007525213A (ja) | 2004-01-27 | 2007-09-06 | コンピュゲン ユーエスエイ，インク． | 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法 |
| JP4825667B2 (ja) * | 2004-03-31 | 2011-11-30 | 一和 中尾 | 関節炎症治療剤又は予防剤 |
| EP3620530A1 (en) * | 2004-03-31 | 2020-03-11 | Kazuwa Nakao | Composition for increasing body height |
| CN101232874A (zh) * | 2004-08-11 | 2008-07-30 | 阿尔扎公司 | 透皮递送利钠肽的装置和方法 |
| EP1810716A1 (de) * | 2005-12-23 | 2007-07-25 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Verfahren zur Bräunung der Haut |
| DE102004048576A1 (de) * | 2004-10-04 | 2006-04-13 | Deutsches Zentrum für Luft- und Raumfahrt e.V. | Methode zur Bräunung der Haut |
| EP2054433B1 (en) | 2006-08-08 | 2017-12-13 | Mayo Foundation For Medical Education And Research | Diuretic and natriuretic polypeptides |
| WO2008032450A1 (fr) | 2006-09-15 | 2008-03-20 | Kyoto University | Agent prophylactique et/ou thérapeutique pour une stéatose hépatique |
| US20120034183A1 (en) | 2006-12-19 | 2012-02-09 | Michael Cohen | Compositions and methods for growing embryonic stem cells |
| JP5010913B2 (ja) * | 2006-12-31 | 2012-08-29 | 寿子 小出 | 心房利尿ホルモンファミリー分子を活性物質として含有する組織再生製剤また該製剤をもちいる組織再生方法、および心房利尿ホルモンファミリー分子を活性物質として含有する発毛、増毛、育毛剤および皮膚組織修復改善剤また該製剤を用いる発毛、増毛、育毛促進方法および皮膚組織修復改善方法 |
| JP2010168283A (ja) | 2007-04-24 | 2010-08-05 | Yamaguchi Univ | ナトリウム利尿ペプチドを有効成分とする肝硬変・前癌病変の抑制剤 |
| WO2008140125A1 (ja) | 2007-05-10 | 2008-11-20 | National University Corporation Nagoya University | 腹膜線維化抑制用医薬組成物 |
| EP2187953A2 (en) * | 2007-09-11 | 2010-05-26 | Mondobiotech Laboratories AG | Use of a peptide as a therapeutic agent |
| CA2699169A1 (en) | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Therapeutic uses of intermedin 47 and 53 peptides |
| AU2008326327A1 (en) * | 2007-11-21 | 2009-05-28 | Biomarin Pharmaceutical Inc. | Variants of C-type natriuretic peptide |
| EP2307447B1 (en) | 2008-07-02 | 2016-03-09 | Mayo Foundation For Medical Education And Research | Natriuretic polypeptides with unique pharmacologic profiles |
| US8642550B2 (en) * | 2008-10-24 | 2014-02-04 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic peptides without hypotensive inducing capability |
| US8150603B2 (en) | 2008-11-26 | 2012-04-03 | Caterpillar Inc. | Engine control system having fuel-based timing |
| WO2010078325A2 (en) | 2008-12-29 | 2010-07-08 | Mayo Foundation For Medical Education And Research | Natriuretic polypeptides for reducing or preventing restenosis |
| PE20120792A1 (es) | 2009-05-20 | 2012-07-27 | Biomarin Pharm Inc | Variantes de peptidos natriureticos de tipo c |
| US20120208756A1 (en) * | 2009-07-23 | 2012-08-16 | Igisu Co., Ltd | Composition for external preparation for skin |
| JP2011024973A (ja) * | 2009-07-24 | 2011-02-10 | Mitsumasa Maeda | 電子ペーパー付き便蓋 |
| RU2502519C2 (ru) | 2009-08-27 | 2013-12-27 | Кёко ЭНДО | Терапевтическое средство для лечения ринита |
| ITPG20090061A1 (it) | 2009-11-27 | 2011-05-28 | Andrea Marcantonini | Impianto mobile per la produzione di calcestruzzo |
| HUE035584T2 (en) | 2011-01-21 | 2018-05-28 | Igisu Co Ltd | A therapeutic agent for the treatment of allopathy |
-
2010
- 2010-07-23 US US13/386,528 patent/US20120208756A1/en not_active Abandoned
- 2010-07-23 WO PCT/JP2010/062459 patent/WO2011010732A1/ja not_active Ceased
- 2010-07-23 CA CA2768810A patent/CA2768810C/en active Active
- 2010-07-23 RU RU2012103653/15A patent/RU2572694C2/ru active
- 2010-07-23 MX MX2012001024A patent/MX2012001024A/es active IP Right Grant
- 2010-07-23 ES ES10802352.4T patent/ES2456502T3/es active Active
- 2010-07-23 NZ NZ597797A patent/NZ597797A/xx unknown
- 2010-07-23 CN CN201610329663.7A patent/CN105999230B/zh active Active
- 2010-07-23 BR BR112012001491-9A patent/BR112012001491B1/pt active IP Right Grant
- 2010-07-23 DK DK10802352.4T patent/DK2457581T3/da active
- 2010-07-23 EP EP10802352.4A patent/EP2457581B1/en active Active
- 2010-07-23 CN CN201410324381.9A patent/CN104189893B/zh active Active
- 2010-07-23 AU AU2010274293A patent/AU2010274293B9/en not_active Ceased
- 2010-07-23 JP JP2011507738A patent/JP4834190B2/ja active Active
- 2010-07-23 KR KR1020127027521A patent/KR101533695B1/ko active Active
- 2010-07-23 CN CN201910657053.3A patent/CN110339346B/zh active Active
- 2010-07-23 KR KR1020117017629A patent/KR101226165B1/ko active Active
- 2010-07-23 CN CN201080032443.9A patent/CN102470163B/zh active Active
-
2011
- 2011-02-18 JP JP2011033976A patent/JP5778440B2/ja active Active
-
2013
- 2013-09-03 US US14/016,637 patent/US9358269B2/en active Active
-
2015
- 2015-07-09 JP JP2015137445A patent/JP6055518B2/ja active Active
-
2016
- 2016-01-22 RU RU2015150099A patent/RU2015150099A/ru not_active Application Discontinuation
- 2016-05-06 US US15/148,470 patent/US9968654B2/en active Active
- 2016-12-02 JP JP2016234905A patent/JP6337071B2/ja active Active
-
2017
- 2017-12-11 US US15/837,964 patent/US10946072B2/en active Active
-
2018
- 2018-05-07 JP JP2018089006A patent/JP2018135381A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012017316A5 (enExample) | ||
| RU2015150099A (ru) | Композиция кожного препарата для наружного применения | |
| RU2019131867A (ru) | Композиция, включающая экзосому, полученную из стволовых клеток, для индукции адипогенной дифференцировки, регенерации жировой ткани, отбеливания кожи или коррекции морщин | |
| JP2013213217A5 (enExample) | ||
| WO2014160145A3 (en) | Immune modulation using peptides and other compositions | |
| WO2014160103A3 (en) | Treatment of skin, including aging skin, to improve appearance | |
| JP2015523973A5 (enExample) | ||
| WO2014160138A3 (en) | Improvement of memory or learning using peptide and other compositions | |
| WO2013098066A3 (de) | Wässrige haar- und hautreinigungszusammensetzungen, enthaltend biotenside | |
| EA201592236A1 (ru) | Частицы с нанесенным покрытием и композиции, включающие такие частицы | |
| WO2013178684A3 (de) | Zusammensetzung enthaltend aminosäuretenside, betaine und n-methyl-n-acylglucamine mit verbesserter schaumqualität und höherer viskosität | |
| JP2009539987A5 (enExample) | ||
| US11026873B2 (en) | Personal care composition comprising taurine, arginine, glycine | |
| WO2014044808A3 (en) | Fast-penetration cosmetic dermal filler for topical application | |
| FR2869913B1 (fr) | Composition tensioactive, procede de preparation et cosmetique comprenant cette composition | |
| WO2012070804A3 (ko) | 올레아놀릭산을 함유하는 화장료 조성물 | |
| WO2013002518A3 (ko) | 화장료 조성물을 포함하는 피부 미용 키트 및 도포방법 | |
| JP2016512246A5 (enExample) | ||
| WO2010008219A3 (ko) | 지방조직 유래 다분화능 줄기세포의 배양물 및 그 추출 단백질을 함유한 화장료용 조성물 | |
| RU2013112014A (ru) | Композиции, содержащие павловнин и/или экстракты павловнии, и их использование | |
| RU2016121390A (ru) | Фармацевтические, косметические и дезинфицирующие композиции для местного применения, содержащие фосфатидилхолин | |
| EA201590177A1 (ru) | Композиция с умеренным пенообразованием для снятия макияжа | |
| BR112018072023A2 (pt) | composição pós-espumante, método de fabricação de uma composição de limpeza pessoal, e, uso de uma composição | |
| RU2014118775A (ru) | Композиции, содержащие экстракты bursera simaruba | |
| JP2013542954A5 (enExample) |